US Bancorp DE Purchases 40 Shares of Cabot Corporation (NYSE:CBT)

US Bancorp DE raised its stake in Cabot Corporation (NYSE:CBT) by 0.2% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 21,540 shares of the specialty chemicals company’s stock after buying an additional 40 shares during the period. US Bancorp DE’s holdings in Cabot Corporation were worth $1,151,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the company. Tower Research Capital LLC TRC boosted its position in shares of Cabot Corporation by 344.9% in the first quarter. Tower Research Capital LLC TRC now owns 2,438 shares of the specialty chemicals company’s stock valued at $146,000 after buying an additional 1,890 shares during the last quarter. Integrated Investment Consultants LLC boosted its position in shares of Cabot Corporation by 66.1% in the second quarter. Integrated Investment Consultants LLC now owns 3,097 shares of the specialty chemicals company’s stock valued at $165,000 after buying an additional 1,233 shares during the last quarter. Meeder Asset Management Inc. boosted its position in shares of Cabot Corporation by 123.1% in the first quarter. Meeder Asset Management Inc. now owns 2,892 shares of the specialty chemicals company’s stock valued at $173,000 after buying an additional 1,596 shares during the last quarter. Timber Hill LLC purchased a new position in shares of Cabot Corporation during the first quarter valued at approximately $201,000. Finally, Oxford Asset Management purchased a new position in shares of Cabot Corporation during the first quarter valued at approximately $205,000. 84.76% of the stock is currently owned by institutional investors.

Cabot Corporation (NYSE:CBT) opened at 51.66 on Friday. Cabot Corporation has a 52-week low of $47.99 and a 52-week high of $61.34. The company has a market cap of $3.21 billion, a price-to-earnings ratio of 14.47 and a beta of 1.05. The stock has a 50 day moving average of $53.37 and a 200-day moving average of $55.55.

Cabot Corporation (NYSE:CBT) last issued its quarterly earnings results on Tuesday, August 1st. The specialty chemicals company reported $0.81 EPS for the quarter, missing analysts’ consensus estimates of $0.85 by $0.04. Cabot Corporation had a net margin of 8.61% and a return on equity of 16.03%. The firm had revenue of $705 million for the quarter, compared to analysts’ expectations of $664.16 million. During the same period in the prior year, the company earned $0.93 EPS. The firm’s quarterly revenue was up 13.5% on a year-over-year basis. On average, analysts forecast that Cabot Corporation will post $3.45 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Friday, August 25th will be given a dividend of $0.315 per share. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $1.26 dividend on an annualized basis and a dividend yield of 2.44%. Cabot Corporation’s dividend payout ratio is presently 35.29%.

TRADEMARK VIOLATION NOTICE: “US Bancorp DE Purchases 40 Shares of Cabot Corporation (NYSE:CBT)” was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.com-unik.info/2017/08/19/cabot-corporation-nysecbt-position-boosted-by-us-bancorp-de-updated.html.

Several analysts recently commented on CBT shares. Jefferies Group LLC restated a “buy” rating and set a $68.00 price target on shares of Cabot Corporation in a report on Tuesday, May 2nd. Zacks Investment Research upgraded shares of Cabot Corporation from a “hold” rating to a “buy” rating and set a $68.00 price target for the company in a report on Friday, April 28th. Northcoast Research upgraded shares of Cabot Corporation from a “neutral” rating to a “buy” rating and set a $63.00 price target for the company in a report on Wednesday, May 24th. BidaskClub upgraded shares of Cabot Corporation from a “hold” rating to a “buy” rating in a report on Thursday, July 6th. Finally, Aegis restated a “hold” rating on shares of Cabot Corporation in a report on Wednesday, May 31st. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $60.50.

Cabot Corporation Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Institutional Ownership by Quarter for Cabot Corporation (NYSE:CBT)

What are top analysts saying about Cabot Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cabot Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit